{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:10:44Z","timestamp":1790727044170,"version":"4.1.0"},"reference-count":58,"publisher":"Informa UK Limited","issue":"9","license":[{"start":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:00:00Z","timestamp":1566518400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Drug Delivery"],"published-print":{"date-parts":[[2019,9,2]]},"DOI":"10.1080\/17425247.2019.1649252","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T13:28:24Z","timestamp":1564579704000},"page":"907-914","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":34,"title":["What place for prolonged-release buprenorphine depot-formulation Buvidal\u00ae in the treatment arsenal of opioid dependence? Insights from the French experience on buprenorphine"],"prefix":"10.1080","volume":"16","author":[{"given":"Florence","family":"Vorspan","sequence":"first","affiliation":[{"name":"D\u00e9partement de Psychiatrie et de M\u00e9decine Addictologique, H\u00f4pital Fernand Widal, Assistance Publique \u2013 H\u00f4pitaux de Paris, Paris, France"},{"name":"Facult\u00e9 de M\u00e9decine, Universit\u00e9 Paris Diderot et INSERM UMRS 1144, Universit\u00e9 Paris Descartes, Universit\u00e9 Paris Diderot, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Hjelmstr\u00f6m","sequence":"additional","affiliation":[{"name":"Camurus AB, Ideon Science Park, Lund, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Simon","sequence":"additional","affiliation":[{"name":"INSERM, IRD, SESSTIM, Hop Sainte Marguerite, Service de Pharmacologie Clinique, CAP, Aix Marseille Univ, Marseille, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amine","family":"Benyamina","sequence":"additional","affiliation":[{"name":"CESP, centre d\u2019enseignement, de recherche et de traitement des addictions, universit\u00e9 Paris Sud, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Dervaux","sequence":"additional","affiliation":[{"name":"Service de Psychiatrie et Addictologie de liaison, CHU Sud, Amiens Cedex, France"},{"name":"Groupe de Recherche sur l\u2019Alcool & les Pharmacod\u00e9pendances (GRAP) INSERM U1247, Amiens, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Brousse","sequence":"additional","affiliation":[{"name":"EA NPsy-Sydo, universit\u00e9 Clermont-Auvergne, Clermont-Ferrand, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Jamain","sequence":"additional","affiliation":[{"name":"CSAPA, Maison des Addictions, CPN, Laxou, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux","family":"Kosim","sequence":"additional","affiliation":[{"name":"Consultations de m\u00e9decine-Alcoologie PASS, Groupe Hospitalier Piti\u00e9 Salp\u00eatri\u00e8re, Paris, France"},{"name":"Camurus SAS, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Rolland","sequence":"additional","affiliation":[{"name":"Service Universitaire d\u2019Addictologie de Lyon (SUAL), CH Le Vinatier, Bron, France"},{"name":"Universit\u00e9 de Lyon, UCBL1, INSERM, INSERM U1028, CNRS UMR 5292, CRNL, Bron, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,8,23]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61530-5"},{"key":"CIT0002","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau1184","volume":"361","author":"Jalal H","year":"2018","journal-title":"Science"},{"key":"CIT0003","first-page":"1","author":"Hedegaard H","year":"2015","journal-title":"NCHS Data Brief"},{"key":"CIT0004","first-page":"1","author":"Chen LH","year":"2014","journal-title":"NCHS Data Brief"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm675152e1"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2018.3126"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2017.1305415"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1276"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1007\/s13181-018-0685-1"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.3206"},{"key":"CIT0011","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32812-X"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2018.08.007"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.648"},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1965.03090080008002"},{"key":"CIT0015","first-page":"447","volume":"125","author":"Fournier E","year":"1974","journal-title":"Ann Med Internet (Paris)"},{"key":"CIT0016","first-page":"459","volume":"125","author":"Deniker P","year":"1974","journal-title":"Ann Med Internet (Paris)"},{"key":"CIT0017","unstructured":"Alderks CE Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment Facilities: 2003\u20132015 (update). The CBHSQ Report [Internet]. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2013. Available from: https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/report_3192\/ShortReport-3192.pdf"},{"key":"CIT0018","unstructured":"2018 European drug report www.emcdda.europa.eu [Internet]. Available from: http:\/\/www.emcdda.europa.eu\/edr2018_en."},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1111\/add.13238"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.0001"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199602000-00010"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2017.1409722"},{"key":"CIT0023","volume":"1550","author":"Sordo L","year":"2017","journal-title":"BMJ"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2003.00352.x"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1080\/00952990701523698"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1111\/add.14059"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.9444793.x"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.01.016"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2017.05.039"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3107"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.3109\/10826089409047374"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.257"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12576"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2018.08.009"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/S2215-0366(15)00366-1"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000045"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001098"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.05.047"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1803982"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.04.029"},{"key":"CIT0041","doi-asserted-by":"crossref","unstructured":"EMCDDA. Country drug report 2018 (Portugal): treatment; 2018. [cited 2019 July 30]. Available from: http:\/\/www.emcdda.europa.eu\/countries\/drug-reports\/2018\/portugal\/treatment_en","DOI":"10.5089\/9781484342923.002"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1080\/10550490490440780"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-007-0046-2"},{"key":"CIT0044","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2016.10.011"},{"key":"CIT0045","first-page":"143","volume":"7","author":"Polom\u00e9ni P","year":"2014","journal-title":"Int J Gen Med"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2018.07.001"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2018.03.003"},{"key":"CIT0048","unstructured":"EMCDDA. Country drug report 2018 (France): treatment; 2018. [cited 2019 July 30]. Available from: http:\/\/www.emcdda.europa.eu\/countries\/drug-reports\/2018\/france\/treatment_en"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1080\/17512433.2017.1336434"},{"key":"CIT0050","unstructured":"European Medicines Agency. Buvidal: summary of product characteristics; 2018. [cited 2019 July 30]. Available from; https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/buvidal-epar-product-information_en.pdf"},{"key":"CIT0051","unstructured":"EMA: European Medicines Agency. Buvidal assessment report from the committee for medicinal products for human use (CHMP), 20 September 2018, EMA\/693347\/2018. Committee for Medicinal Products for Human Use (CHMP), Procedure No. EMEA\/H\/C\/004651\/0000"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2018.1052"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1111\/add.14636"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2017.1874"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2018.03.057"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0296-4"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2004.00728.x"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1186\/s13722-016-0065-6"}],"container-title":["Expert Opinion on Drug Delivery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17425247.2019.1649252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,5]],"date-time":"2020-09-05T00:04:21Z","timestamp":1599264261000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17425247.2019.1649252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,23]]},"references-count":58,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9,2]]}},"alternative-id":["10.1080\/17425247.2019.1649252"],"URL":"https:\/\/doi.org\/10.1080\/17425247.2019.1649252","relation":{},"ISSN":["1742-5247","1744-7593"],"issn-type":[{"value":"1742-5247","type":"print"},{"value":"1744-7593","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,23]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iedd20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-07-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-07-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}